News and Resources

April 23, 2024

Young mice plasma sevs: unlocking the secret to longevity

Read More
April 9, 2024

Telomir-1: the next breakthrough in anti-aging therapy

Read More
March 26, 2024

Surprising longevity boosters: top medications revealed

Read More
March 12, 2024

Patent spotlight: zip11 gene and the future of anti-aging therapies

Read More
February 27, 2024

Harvard's youth protein: turning back the aging clock

Read More
January 23, 2024

Immorta Bio Welcomes Dr. Vlad Bykoriz as its Chief Medical Officer

Read More
January 2, 2024

Immorta Bio Announces Personalized Progenitor Cell Platform for Organ Specific Regeneration

Read More
December 18, 2023

Immorta Bio Files Patent on Reversing Cellular Aging by Creation of Personalized Regenerative Cells

Read More
December 6, 2023

Venvalo Group Launches Immorta Bio, Inc Aimed at Providing Unlimited Personalized Cells for Treating Diseases of Aging and Treating Aging as Disease™

Read More
Get The Latest News and Developments On Our Longevity Journey
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
By subscribing, you are acknowledging your consent to receive  Immorta Bio newsletters
19505 Biscayne Blvd, Ste 2350 Aventura, Florida 33180
305 632-2939
info@immortabio.com
Social Media
Technologies
StemCell Revivify™
SenoVax™
Pipeline
Immorta Bio Therapeutics Pipeline
About Us
Management Team
Patents
News and Resources
News
Investors
Contact Us
Copyright © Immorta Bio, Inc | All Rights Reserved
Privacy Policy